Retina Synthesis Podcast
1) New Developments in Treating ROP
In our latest update, we discuss current treatment of retinopathy of prematurity as well as new developments in disease prevention with Dr. Darius Moshfeghi, Professor of Ophthalmology, Stanford Unive...Show More
2) TKI Drugs in the Treatment of nAMD and DME
In this update, we review the TKI program of Eyepoint Pharmaceuticals with Dr. Jay Duker, President and CEO.
3) Artificial Intelligence and Home OCT for nAMD
We discuss a study that showed that an artificial intelligence powered system can detect clinically significant fluid as well as experienced observers using the Notal Home OCT with Dr. Ted Leng, Profe...Show More
4) Undertreatment of Diabetic Macular Edema: A Clinical Challenge
We discuss studies documenting the undertreatment of diabetic macular edema and possible strategies for alleviating it with Dr. Matthew Starr, Assistant Professor, Mayo Clinic, Rochester, Minnesota.
5) Suprachoroidal Gene Therapy for Nonproliferative Diabetic Retinopathy
In this episode, we discuss promising results of gene therapy, administered suprachoroidally, for the treatment of nonproliferation diabetic retinopathy without macular edema with Charles Wykoff, MD, ...Show More
6) Optogenetics for Treating Inherited Retinal Degenerations
We discuss promising Phase 2 results from Nanoscope regarding the use of optogenetics for treatment of retinal degenerations with Allen Ho, MD, Professor of Ophthalmology, Wills Eye Hospital.
7) Untitled EpisodeArtificial Intelligence in the Management of Macular Disease
We discuss the early results of the use of artificial intelligence in the management of macular disorders with Dr. Pearse Keane, the world's first Professor of Artificial Medical Intelligence, Univers...Show More
Untitled EpisodeArtificial Intelligence in the Management of Macular Disease
24:12 | Dec 3rd, 2025
8) Stem Cell Therapy for Geographic Atrophy
We discuss with Dr. Rajesh C. Rao, Leonard Miller Professor of Ophthalmology, Kellogg Eye Center, University of Michigan, the results of a Phase I trial exploring the use of stem cells injected subret...Show More
9) Intravitreal Gene Therapy for Neovascular AMD
We discuss the early results of gene therapy of neovascular AMD by intravitreal administration of the vector with Dr. Glenn Yiu, Professor of Ophthalmology, University of California, Davis.
10) The TRUCKEE Study of Faricimab for Neovascular AMD
We discuss the long term results of the Truckee Study, a stage 4 clinical trial in the treatment of neovascular AMD with faricimab with Dr. Arshad Khanani from Sierra Eye Associates, Reno, Nevada.